%0 Journal Article
%T Lipopolysaccharide impairs amyloid beta efflux from brain: altered vascular sequestration, cerebrospinal fluid reabsorption, peripheral clearance and transporter function at the blood¨Cbrain barrier
%A Michelle A Erickson
%A Pehr E Hartvigson
%A Yoichi Morofuji
%A Joshua B Owen
%A D Allan Butterfield
%A William A Banks
%J Journal of Neuroinflammation
%D 2012
%I BioMed Central
%R 10.1186/1742-2094-9-150
%X CD-1 mice aged between 6 and 8£¿weeks were treated with 3 intraperitoneal injections of 3£¿mg/kg LPS at 0, 6, and 24 hours and studied at 28 hours. 125I-A¦Â1-42 or 125I-alpha-2-macroglobulin injected into the lateral ventricle of the brain (intracerebroventricular (ICV)) or into the jugular vein (intravenous (IV)) was used to quantify LRP-1-dependent partitioning between the brain vasculature and parenchyma and peripheral clearance, respectively. Disappearance of ICV-injected 14£¿C-inulin from brain was measured to quantify bulk flow of cerebrospinal fluid (CSF). Brain microvascular protein expression of LRP-1 and Pgp was measured by immunoblotting. Endothelial cell localization of LRP-1 was measured by immunofluorescence microscopy. Oxidative modifications to LRP-1 at the brain microvasculature were measured by immunoprecipitation of LRP-1 followed by immunoblotting for 4-hydroxynonenal and 3-nitrotyrosine.We found that LPS: caused an LRP-1-dependent redistribution of ICV-injected A¦Â from brain parenchyma to brain vasculature and decreased entry into blood; impaired peripheral clearance of IV-injected A¦Â; inhibited reabsorption of CSF; did not significantly alter brain microvascular protein levels of LRP-1 or Pgp, or oxidative modifications to LRP-1; and downregulated LRP-1 protein levels and caused LRP-1 mislocalization in cultured brain endothelial cells.These results suggest that LRP-1 undergoes complex functional regulation following systemic inflammation which may depend on cell type, subcellular location, and post-translational modifications. Our findings that systemic inflammation causes deficits in both A¦Â transport and bulk flow like those observed in AD indicate that inflammation could induce and promote the disease.
%K Alzheimer¡¯s disease
%K amyloid beta
%K blood¨Cbrain barrier
%K inflammation
%K lipopolysaccharide
%K LRP1
%K Pgp
%K ABCB1
%K MDR1
%K cerebrospinal fluid
%U http://www.jneuroinflammation.com/content/9/1/150/abstract